CPNP and SCPN are notifications, not product approvals. A private-label buyer still needs a compliant formula, safety assessment, product information, label and responsible-person arrangement before market placement. EU CPNP and UK SCPN projects diverge after Brexit: Great Britain uses the UK notification service and requires a UK-established Responsible Person, while EU placement follows the EU framework and portal.
Map market and Responsible Person
Decide whether products will enter EU, Great Britain or Northern Ireland and obtain current regulatory advice for each route. Identify the legal Responsible Person and address that will appear on pack. An overseas OEM does not automatically fill that role.
Build the PIF and safety package
Provide quantitative formula, raw-material specifications, impurities, safety data, manufacturing method, GMP statement, stability, microbiology, packaging and claim support. The safety assessor needs complete composition of peptide stock solutions, not hero active names only.
Prepare correct labels
Review ingredient list, nominal content, durability or PAO, precautions, batch code, function and responsible-person details as applicable. Stock-solution carriers and preservatives must flow into the finished INCI. Translate required information for destination markets.
Notify with the sold product data
The EU portal requires information under the cosmetics regulation; Great Britain requires notification through SCPN before placement. GOV.UK guidance lists product category, Responsible Person, PIF location, ingredient summary and label/package images among preparation items.
Control formula and artwork changes
A peptide supplier change can alter composition, safety assessment, label and notification. Route changes through regulatory review before production. Keep effective dates so existing inventory and new formula are not confused.
Get an OEM handover package
The agreement should state who supplies formula, COAs, SDS, manufacturing statement, stability, challenge test, batch records, samples and change notices. A certificate saying CPNP ready is not a complete PIF.
Avoid misleading approval language
Do not advertise CPNP registered as EU approved. Notification does not mean authority endorsement. Claims still require truthful, relevant evidence and must remain within cosmetic scope.
A pre-notification reconciliation meeting
Before submission, place the signed formula, CPSR or safety documentation, label artwork, package photograph, ingredient declaration and notification draft on one screen. Regulatory, brand and OEM representatives should confirm product name, shade or variant, Responsible Person, formula version and claims. Resolve carrier ingredients missing from the INCI and ensure the notified formula matches commercial manufacture. Record approval and lock the version. This short meeting prevents a technically successful notification from describing a different product than the one packed for sale.
Questions buyers also ask
Is CPNP registration an EU approval?
No. CPNP is a notification system; compliance and safety responsibilities remain with the Responsible Person.
Does a UK product need SCPN after Brexit?
Cosmetics placed on the Great Britain market require notification through the UK service under the applicable rules.
Can an OEM submit the notification for a brand?
Roles depend on legal arrangements, but the Responsible Person and complete product data must be established before notification.
Selected official sources
Review a real specification
Send the peptide grade, active basis, formula, package, quantity and destination market for a technical document review.
Send a B2B inquiryPublished August 19, 2026. Technical B2B guidance; not medical or legal advice.